Research Article

Microarray Analysis and Detection of MicroRNAs Associated with Chronic Thromboembolic Pulmonary Hypertension

Table 1

The baseline characteristics of the 9 samples.

SexCollection dateAgeBMI (kg/m2)Family history of blood clotsSmokingLong periods of inactivityOther CTEPH risk factors

CTEPH group
160039K-1MaleMarch 20164125.99No15 years, quit smoking for 3 yearNoNo
160039K-2MaleMarch 20166723.66No40 years, quit smoking for 4 yearNoNo
160039K-3FemaleMarch 20165327.99NoNoNoUnilateral lower extremity edema, a year before onset
160039L-1FemaleMarch 20167118.96NoNoNoVaricosity
Control group
160039J-6MaleApril 201650/No/NoNo
160039J-7MaleApril 201656/No/NoNo
160039J-8FemaleApril 201671/No/NoNo
160039J-9FemaleApril 201664/No/NoNo
160039J-10MaleApril 201650/No/NoNo

For smoking, we did not investigate this information for control group, but there was no correction between smoking and CTEPH according to previous studies. For BMI, we did not investigate this information for control group. 160039K-1, 160039K-2, 160039K-3, 160039L-1, 160039J-6, 160039J-7, 160039J-8, 160039J-3, and 160039J-10 were chip number.